A company called iCoreConnect bought another company called Verifi Dental. This is good news for iCoreConnect because it helps them make more software solutions for hospitals and dentists, which makes people want to buy their shares. The CEO of iCoreConnect says this is a smart move that will help the company grow. Read from source...

- The headline is misleading and clickbaity. It does not accurately reflect the content of the article, which is mainly about an acquisition deal and its expected benefits for iCoreConnect and Verifi Dental, rather than the reason behind the surge in ICCT shares.
- The author uses vague terms such as "rocketing" and "surging" without providing any concrete data or metrics to support them. For example, what is the percentage increase in ICCT share price? What is the market capitalization of iCoreConnect and Verifi Dental? How does this performance compare to their competitors or industry benchmarks?
- The author relies on quotes from Robert McDermott, the CEO of iCoreConnect, without questioning his motives, credibility, or potential conflicts of interest. For example, how can he claim that this acquisition is a "strategic" and "positive" move for the company, when it may also have negative consequences such as increased debt, dilution of shareholders' value, integration challenges, etc.? How does he measure the "enhanced capabilities", "broader market presence", and "improved value" that this deal will bring to customers and stakeholders?

As an AI model that can do anything now, I have carefully analyzed the article titled "Why Software & Technology Company iCoreConnect Shares Are Rocketing Today". Based on my analysis, here are my comprehensive investment recommendations and risks for iCoreConnect (ICCT) shares.